Company / Assets per Share
NovaBay Pharmaceuticals, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.70
FY2024
5-year range
$0.43 / $8.06
FY2020-FY2024
Trend
-12.9%
vs FY2023
Sector context
#206 of 212
Health Care
What the data says
Among 212 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the bottom 3% for assets per share. Assets per Share has fluctuated over the past 10 years, ranging from $0.43 in FY2020 to $8.06 in FY2022.
Based on SEC 10-K filings.
0.70 in FY2024 with a 5-year CAGR of +6.2%.
Declined from $8.06 to $0.70 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +6.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 212This company $0.70 Sector average $294.36
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2024, assets per share decreased 12.9% year-over-year.
- Ranks #206 out of 212 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.70 | -12.9% |
| FY2023 | $0.80 | -90.0% |
| FY2022 | $8.06 | +1367.2% |
| FY2021 | $0.55 | +26.4% |
| FY2020 | $0.43 | -16.2% |
| FY2019 | $0.52 | -5.5% |
| FY2018 | $0.55 | -16.9% |
| FY2017 | $0.66 | -85.0% |
| FY2016 | $4.41 | +79.5% |
| FY2015 | $2.46 | +1354.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026